12/31/2020 | LM | Market Commentary: Outlook 2021: Host of multi-billion-dollar offers dot liability management in 2020; LatAm active
|
5/13/2020 | IG | Fitch ups, withdraws Allergan
|
5/13/2020 | IGLM | AbbVie gets tenders for $13.99 billion, €3.06 billion Allergan notes
|
5/8/2020 | BKIG | S&P upgrades Allergan
|
5/5/2020 | IGLM | AbbVie extends exchange for Allergan notes for expected last time
|
4/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
4/20/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more week
|
4/6/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
3/23/2020 | IGLM | Abbvie extends exchange offers for Allergan notes by two more weeks
|
2/24/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by two more weeks
|
1/27/2020 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
12/31/2019 | IG | Market Commentary: Outlook 2020: High-grade bond supply to decline for third year; merger funding needs drop
|
12/20/2019 | IGLM | AbbVie extends exchange offers for Allergan notes by one more month
|
11/22/2019 | IG | Market Commentary: Light supply eyed for holiday week; Intel, Dominion Energy soft; AbbVie firms; Westpac stable
|
11/18/2019 | IGLM | AbbVie extends exchange offers for Allergan notes to Dec. 31
|
11/18/2019 | IGLM | AbbVie extends exchange offers for Allergan notes to Dec. 31
|
11/12/2019 | EMHYPFPV | Market Commentary: Ford prices split-rated tap; Westpac offers dollar notes; heavy high-grade volume in pipeline
|
11/12/2019 | IG | Market Commentary: Ford prices split-rated tap; Westpac offers dollar notes; heavy high-grade volume in pipeline
|
11/8/2019 | EMHYPFPV | Market Commentary: JPMorgan prices $750 million tap; heavy volume expected in week ahead
|
11/8/2019 | IG | Market Commentary: JPMorgan prices $750 million tap; heavy volume expected in week ahead; Credit Suisse firms
|
11/7/2019 | IGLM | AbbVie announces early participation results of exchange offer for 18 series of Allergan notes
|
11/7/2019 | EMHYPFPV | Market Commentary: Patterson-UTI prices downsized notes; FHLBank prints; Hasbro considers deal
|
11/7/2019 | IG | Market Commentary: Patterson-UTI prices downsized notes; FHLBank prints; Hasbro considers deal; inflows reported
|
11/6/2019 | EMHYPFPV | Market Commentary: Cheniere, Vistra, Equinix, Healthpeak, Ryder, SEK price; AbbVie markets deal
|
11/6/2019 | IG | Market Commentary: Cheniere, Vistra, Equinix, Healthpeak, Ryder, SEK price; AbbVie markets multiple-tranche deal
|
11/6/2019 | IG | AbbVie launches offering of senior notes to fund Allergan merger
|
10/25/2019 | IGLM | AbbVie launches exchange offer for 18 series of Allergan notes
|
8/20/2019 | SP | New Issue: RBC sells $135,000 contingent coupon barrier autocalls on three stocks
|
6/28/2019 | BKIG | Fitch might lift Allergan
|
6/26/2019 | IG | Market Commentary: High-grade registered primary market quiets; Telus prices; FS KKR Capital considers bond deal
|
6/26/2019 | IG | Market Commentary: High-grade registered primary market quiets; Telus prices; FS KKR Capital considers bond deal
|
6/26/2019 | IG | Hefty high-grade debt offering eyed for AbbVie, Allergan merger
|
6/25/2019 | BKIG | AbbVie gets $38 billion bridge loan to acquire Allergan, repay debt
|
6/25/2019 | BKIG | S&P puts Allergan on positive watch
|
6/25/2019 | BKIG | Moody’s might up Allergan plc
|
3/18/2019 | IG | Fitch changes Allergan view
|
3/5/2019 | SP | New Issue: JPMorgan sells $1 million contingent interest autocallables tied to Allergan
|
2/27/2019 | SP | JPMorgan plans 7.8% contingent interest autocalls tied to Allergan
|
2/19/2019 | SP | New Issue: RBC prices $1.61 million 11% callable notes on three pharma stocks
|
2/12/2019 | SP | RBC plans to price 11% callable notes linked to three pharma stocks
|
1/11/2019 | SP | New Issue: JPMorgan sells $4.05 million digital dual directional contingent buffered notes on Allergan
|
12/28/2018 | SP | New Issue: Barclays prices $4.45 million autocallable trigger jump securities on Allergan
|
11/16/2018 | SP | Barclays eyes trigger jump securities due 2021 tied to Allergan stock
|
11/14/2018 | SP | New Issue: Barclays sells $1.07 million phoenix autocallable notes on stocks, ETF
|
11/8/2018 | CVIG | Fitch rates Allergan notes BBB-
|
11/8/2018 | CVIG | Moody's rates Allergan notes Baa3
|
11/8/2018 | IG | S&P rates Allergan notes BBB
|
9/25/2018 | SP | New Issue: UBS prices $130,000 8.9% contingent yield trigger autocalls tied to two stocks
|
9/24/2018 | SP | New Issue: RBC prices $284,000 10.1% contingent coupon autocalls on three stocks
|
9/20/2018 | SP | New Issue: UBS sells $130,000 trigger autocallable contingent yield notes on Allergan, Johnson & Johnson
|
9/11/2018 | SP | New Issue: JPMorgan sells $2.02 million contingent interest autocallables tied to Allergan
|
8/22/2018 | SP | New Issue: Barclays prices $1.84 million contingent income autocalls on Allergan
|
8/15/2018 | SP | Barclays plans 8.3% contingent income autocallables linked to Allergan
|
8/8/2018 | SP | New Issue: RBC sells $1.4 million contingent coupon barrier autocalls on three stocks
|
7/16/2018 | SP | New Issue: Citigroup sells $1.94 million contingent coupon autocallables on Allergan, Merck
|
6/19/2018 | SP | Citi plans 9% to 10% contingent coupon autocalls on Allergan, Merck
|
6/6/2018 | SP | New Issue: Credit Suisse sells $1.41 million contingent coupon autocallable yield notes on stocks
|
5/30/2018 | SP | JPMorgan plans 9.75% contingent interest autocalls on three stocks
|
5/16/2018 | SP | New Issue: Deutsche Bank sells $3.79 million 10.6% one-year securities on Allergan
|
4/30/2018 | SP | New Issue: Wells Fargo prices $269,000 11.6% contingent market-linked autocalls on stocks
|
4/10/2018 | SP | Wells Fargo plans 11.3%-12.3% contingent coupon autocalls on stocks
|
3/19/2018 | SP | New Issue: UBS prices $140,000 return optimization securities linked to Allergan
|
3/8/2018 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Allergan
|
2/15/2018 | SP | New Issue: JPMorgan prices $4.88 million contingent income autocalls on Allergan
|
2/14/2018 | SP | New Issue: Morgan Stanley prices $4.18 million contingent income autocalls tied to Allergan
|
2/12/2018 | SP | New Issue: UBS sells $5.4 million 8% contingent yield trigger autocalls tied to Allergan
|
2/9/2018 | SP | New Issue: Citigroup sells $572,000 autocallable equity-linked notes tied to pharma stocks
|
2/7/2018 | IG | S&P changes Allergan to stable
|
2/5/2018 | SP | New Issue: Wells Fargo prices $2.67 million 11.15% contingent market-linked autocalls on stocks
|
1/26/2018 | SP | New Issue: JPMorgan prices $1.1 million 10% contingent interest autocalls tied to Allergan
|
1/11/2018 | SP | Wells Fargo plans 10.15%-11.15% contingent coupon market-tied autocalls tied to three stocks
|
1/8/2018 | SP | New Issue: UBS prices $10.07 million trigger phoenix autocallables linked to Allergan
|
12/27/2017 | SP | New Issue: UBS prices $305,000 airbag yield optimization notes linked to Allergan
|
11/28/2017 | SP | New Issue: UBS prices $250,000 return optimization securities linked to Allergan
|
11/21/2017 | SP | New Issue: HSBC prices $1.95 million 7.6% contingent income barrier autocalls tied to stocks
|
11/16/2017 | SP | New Issue: JPMorgan prices $1.86 million contingent interest autocalls on Allergan
|
11/6/2017 | SP | New Issue: Barclays prices $9.66 million contingent income autocallables linked to Allergan
|
10/20/2017 | SP | New Issue: UBS prices $800,000 trigger phoenix autocallables linked to Allergan
|
10/20/2017 | SP | New Issue: UBS prices $850,000 trigger phoenix autocallables linked to Allergan
|
10/19/2017 | SP | UBS to price trigger autocallable contingent yield notes on Allergan
|
10/10/2017 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallables linked to Allergan
|
9/29/2017 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Allergan
|
9/28/2017 | SP | New Issue: UBS prices $11.2 million 7% airbag autocallables linked to Allergan
|
9/27/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Allergan
|
9/27/2017 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Allergan
|
9/27/2017 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallables linked to Allergan
|
9/27/2017 | SP | New Issue: UBS prices $6.3 million trigger phoenix autocallables linked to Allergan
|
9/25/2017 | SP | UBS plans to price 6.5%-7.5% airbag autocallables linked to Allergan
|
9/25/2017 | SP | CIBC corrects Cusips for Raymond James Healthcare Top Selections notes
|
9/22/2017 | SP | New Issue: UBS prices $700,000 airbag yield optimization notes linked to Allergan
|
7/27/2017 | CV | Market Commentary: U.S. convertibles mixed as earnings in focus; recently priced Teladoc adds dollar neutral
|
7/26/2017 | SP | New Issue: CIBC sells $443,000 Raymond James Healthcare Top Selections notes tied to 14 stocks
|
7/26/2017 | SP | New Issue: CIBC sells $4.82 million Raymond James Healthcare Top Selections notes on 14 stocks
|
7/20/2017 | SP | CIBC to price notes on 14 Raymond James top pick healthcare stocks
|
7/20/2017 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 14 stocks
|
5/24/2017 | IGLM | Allergan gives early tally, ups tender cap to $2.8 billion; pricing set
|
5/24/2017 | IGLM | Allergan gives early tender results, lifts offer cap to $2.84 billion
|
5/23/2017 | IG | Fitch rates Allergan notes BBB-
|
5/23/2017 | IG | Moody’s rates Allergan notes Baa3
|
5/23/2017 | IG | S&P rates Allergan euro notes BBB
|
5/10/2017 | IGLM | Allergan begins one-month tender for up to $2 billion of several notes
|
3/27/2017 | SP | New Issue: HSBC prices $5.81 million contingent income autocallables linked to Allergan
|
3/22/2017 | SP | HSBC plans contingent income autocallable notes linked to Allergan
|
3/15/2017 | SP | New Issue: UBS prices $1.02 million contingent absolute return autocallable optimization securities linked to Allergan
|
2/24/2017 | SP | New Issue: UBS prices $525,000 trigger phoenix autocallables linked to Allergan
|
1/6/2017 | SP | New Issue: UBS prices $465,000 contingent absolute return autocallable optimization securities linked to Allergan
|
1/6/2017 | SP | New Issue: UBS prices $1.01 million contingent absolute return autocallable optimization securities linked to Allergan
|
1/6/2017 | SP | New Issue: UBS prices $201,500 contingent absolute return autocallable optimization securities linked to Allergan
|
1/6/2017 | SP | New Issue: UBS prices $1.93 million contingent absolute return autocallable optimization securities linked to Allergan
|
1/6/2017 | SP | New Issue: UBS prices $135,000 contingent absolute return autocallable optimization securities linked to Allergan
|
1/6/2017 | SP | New Issue: UBS prices $400,000 contingent absolute return autocallable optimization securities linked to Allergan
|
12/30/2016 | SP | New Issue: Credit Suisse sells $656,000 of 14.35% autocallable yield notes on three stocks
|
12/22/2016 | SP | Credit Suisse plans contingent coupon autocallables on three stocks
|
12/13/2016 | SP | New Issue: Credit Suisse prices $8.68 million 8.6% airbag autocallables linked to Allergan
|
12/8/2016 | SP | New Issue: UBS prices $395,000 airbag yield optimization notes linked to Allergan
|
12/8/2016 | SP | New Issue: UBS prices $515,000 trigger phoenix autocallables linked to Allergan
|
12/7/2016 | SP | Credit Suisse plans 6.8%-8.8% airbag autocallables linked to Allergan
|
12/6/2016 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Allergan
|
10/25/2016 | SP | New Issue: Barclays prices $1.34 million phoenix autocallables tied to Allergan
|
10/19/2016 | SP | Barclays plans to price phoenix autocallables linked to Allergan
|
10/7/2016 | SP | New Issue: HSBC prices $5.49 million income notes linked to 20 stocks
|
9/26/2016 | SP | New Issue: RBC prices $3.39 million trigger phoenix autocallables linked to Allergan
|
9/9/2016 | SP | HSBC plans six-year income notes linked to 20 stocks with 0.5% floor
|
8/30/2016 | SP | New Issue: HSBC prices $2.54 million income notes linked to 20 stocks
|
8/25/2016 | SP | New Issue: RBC prices $2 million contingent coupon barrier autocallables tied to two stocks
|
8/17/2016 | SP | HSBC plans six-year income notes linked to 20 stocks with 0.5% floor
|
8/9/2016 | SP | New Issue: JPMorgan prices $1.66 million contingent interest autocallables linked to Allergan
|
8/9/2016 | CVIG | S&P upgrades Allergan
|
8/4/2016 | BK | Allergan repays, cancels $1 billion revolver upon asset sale to Teva
|
8/1/2016 | SP | New Issue: Credit Suisse prices $5.94 million contingent coupon autocallable yield notes on Allergan
|
7/22/2016 | SP | Credit Suisse plans contingent coupon autocallable yield notes on Allergan
|
7/13/2016 | EMHYMUPFPV | Market Commentary: Japan Bank, Bank of Montreal, International Finance in primary; Anheuser-Busch flat on day
|
7/13/2016 | IG | Market Commentary: Japan Bank, Bank of Montreal, International Finance in primary; Anheuser-Busch flat on day
|
6/14/2016 | SP | New Issue: JPMorgan prices $1.06 million trigger autocallables linked to Allergan
|
6/8/2016 | SP | JPMorgan plans 8% trigger autocallable contingent yield notes on Allergan
|
5/20/2016 | SP | New Issue: Barclays prices $1 million digital notes linked to Allergan shares
|
5/17/2016 | SP | HSBC plans one-year phoenix quarterly review notes linked to Allergan
|
5/6/2016 | PP | Market Commentary: Teva bonds improve on lower shares; Allergan mandatory drops; Chesapeake extends gains
|
5/6/2016 | CV | Market Commentary: Teva bonds improve on lower shares; Allergan mandatory drops; Chesapeake extends gains
|
4/28/2016 | CV | Market Commentary: Xilinx slides as outlook disappoints; energy names continue to outperform; Chesapeake up
|
4/28/2016 | CV | Market Commentary: Morning Commentary: Stone Energy steady as shares fall; Xilinx hit after earnings; Knowles on tap
|
4/26/2016 | SP | New Issue: RBC prices $8.89 million 8% airbag autocallables linked to Allergan
|
4/21/2016 | SP | RBC plans 6.3%-8.3% airbag autocallable yield notes linked to Allergan
|
4/19/2016 | SP | New Issue: Deutsche Bank prices $4.32 million phoenix autocallables on Allergan
|
4/15/2016 | SP | JPMorgan plans single observation reverse exchangeables on Allergan
|
4/15/2016 | SP | New Issue: JPMorgan prices $2 million digital dual directional notes on Allergan
|
4/13/2016 | SP | Deutsche Bank plans to price phoenix autocallables linked to Allergan
|
4/12/2016 | SP | JPMorgan plans digital dual direction contingent buffer notes on stock
|
4/11/2016 | PP | Market Commentary: Convertibles firm; Alcoa better ahead of earnings; Allergan in line; Chesapeake trades up
|
4/11/2016 | CV | Market Commentary: Convertibles firm; Alcoa better ahead of earnings; Allergan in line; Chesapeake trades up
|
4/6/2016 | EMHYMUPFPV | Market Commentary: KfW, Banque Federative, Swedish Export bring deals; Pfizer widens; Newell Rubbermaid firms
|
4/6/2016 | IG | Market Commentary: KfW, Banque Federative, Swedish Export Credit do deals; Pfizer widens; Newell Rubbermaid firms
|
4/4/2016 | EMHYMUPFPV | Market Commentary: Primary sees $12 billion issuance from Target, BMW, others; Pfizer, AT&T tighten modestly
|
4/4/2016 | IG | Market Commentary: Primary sees $12 billion of issuance from Target, BMW, others; Pfizer, AT&T tighten modestly
|
11/24/2015 | IG | Market Commentary: Morning Commentary: Allergan tightens; Wells Fargo paper improves; credit spreads ease
|
11/24/2015 | CVIG | Fitch puts Allergan on positive watch
|
11/23/2015 | CVIG | Moody’s reviews Allergan, Actavis, Forest
|
11/2/2015 | SP | New Issue: RBC prices $1 million 11.8% autocallable reverse convertibles tied to Allergan
|
10/30/2015 | PP | Market Commentary: Integrated Device Technology adds outright on debut; Allergan active, trades in line
|
10/30/2015 | CV | Market Commentary: Integrated Device Technology adds outright on debut; Allergan active, trades in line
|
10/30/2015 | CV | Market Commentary: Morning Commentary: New Integrated Device Technology adds on debut; Allergan trades in line
|
10/29/2015 | PP | Market Commentary: Allergan mandatory edges higher on news of deal talks; Peabody sinks to new lows; NXP, Rovi shares drop
|
10/29/2015 | CV | Market Commentary: Allergan mandatory edges higher on news of deal talks; Peabody sinks to new lows; NXP, Rovi shares drop
|
10/29/2015 | CV | Market Commentary: Morning Commentary: Allergan mandatory edges higher on deal talks; Rovi drops after missing estimates
|
10/1/2015 | SP | JPMorgan plans contingent interest autocallable notes tied to Allergan
|
9/23/2015 | SP | New Issue: Barclays prices $1.42 million trigger phoenix autocallables linked to Allergan
|
9/16/2015 | SP | Barclays plans trigger phoenix autocallables linked to Allergan
|
7/28/2015 | BKCVIG | S&P might lift Allergan
|
7/28/2015 | BKCVIG | Fitch affirms Allergan
|
7/27/2015 | BKBWEMIGLM | Teva Pharmaceuticals to obtain up to $27 billion of debt to buy Allergan’s generics business
|
6/17/2015 | BKCVIG | S&P affirms Allergan on Kythera acquisition
|